Bionano Genomics (NASDAQ:BNGO) will release its quarterly earnings report on Wednesday, 2024-11-13. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bionano ...

Bionano Genomics, Inc. announced a settlement agreement that modifies its existing senior secured convertible debentures due in May 2024. The amendment defers the December 2024 amortization payment ...

Bionano Genomics BNGO is set to give its latest quarterly earnings report on Thursday, 2025-08-14. Here's what investors need to know before the announcement. Analysts estimate that Bionano Genomics ...

Bionano projects full-year 2025 revenues to be in the range of $29 million to $32 million, supported by its strategic focus on routine users. First-quarter 2025 revenues are expected to range from ...

Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...

Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

Cash, cash equivalents, and available-for-sale securities as of December 31, 2024 were $20.9M, of which $11.4M was subject to certain restrictions.”2024 has been an important year for Bionano. Despite ...

Holmlin reiterated, "We are reiterating our full year 2025 revenue guidance of $26 million to $30 million. We expect the fourth quarter of 2025 revenues to be in the range of $7.5 million to $7.9 ...

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) (“Bionano” or the “Company”) today announced the pricing of a public offering of an aggregate of 5,000,000 shares of the ...

SAN DIEGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr® system, a genome imaging platform for ...

In this era of personalized medicine, individualized gene mapping is key – which is why San Diego startup BioNano Genomics’ Irys System just attracted a robust infusion of cash. The company just ...

Operator: Good day and thank you for standing by. Welcome to the Bionano Q2 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there ...